194 related articles for article (PubMed ID: 14671964)
1. [Question 5. What management of hepatobiliary injury in the course of cystic fibrosis? Physiopathology and diagnostic criteria of hepatobiliary injury in the course of cystic fibrosis].
Belli DC
Arch Pediatr; 2003 Aug; 10 Suppl 3():487s-489s. PubMed ID: 14671964
[No Abstract] [Full Text] [Related]
2. Hepatobiliary complications of cystic fibrosis.
Feranchak AP
Curr Gastroenterol Rep; 2004 Jun; 6(3):231-9. PubMed ID: 15128491
[TBL] [Abstract][Full Text] [Related]
3. [Question 5. What management in hepatobiliary injury in the course of cystic fibrosis? Specific therapeutic strategy of hepatobiliary injury in the course of cystic fibrosis].
Debray D
Arch Pediatr; 2003 Aug; 10 Suppl 3():490s-494s. PubMed ID: 14671965
[No Abstract] [Full Text] [Related]
4. Animal models of gastrointestinal and liver diseases. Animal models of cystic fibrosis: gastrointestinal, pancreatic, and hepatobiliary disease and pathophysiology.
Olivier AK; Gibson-Corley KN; Meyerholz DK
Am J Physiol Gastrointest Liver Physiol; 2015 Mar; 308(6):G459-71. PubMed ID: 25591863
[TBL] [Abstract][Full Text] [Related]
5. [Hepatobiliary disease in cystic fibrosis].
Pérez-Aguilar F; Berenguer Lapuerta J
Med Clin (Barc); 1998 Sep; 111(8):302-6. PubMed ID: 9810550
[No Abstract] [Full Text] [Related]
6. Cystic fibrosis-associated liver disease.
Herrmann U; Dockter G; Lammert F
Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):585-92. PubMed ID: 20955961
[TBL] [Abstract][Full Text] [Related]
7. Screening for liver disease in cystic fibrosis: analysis of clinical and genetic risk factors for its development.
Fustik S; Trajkovska M; Jakovska T; Spirevska L; Josifovska T; Koceva S
Turk J Pediatr; 2008; 50(6):526-32. PubMed ID: 19227414
[TBL] [Abstract][Full Text] [Related]
8. Assessment of liver disease in cystic fibrosis.
Davison S
Paediatr Respir Rev; 2018 Jun; 27():24-27. PubMed ID: 29933897
[TBL] [Abstract][Full Text] [Related]
9. ELX/TEZ/IVA use in cystic fibrosis liver disease: Is the perspective of improved lung function worth the risk?
Gardiner A; Volovets A; Haber P; Jo H; Visser S; Yozghatlian V; Taylor N; Nolan S; Dentice R; Malouf M; Marinelli T; Sivam D
J Cyst Fibros; 2022 Sep; 21(5):881-884. PubMed ID: 35760705
[No Abstract] [Full Text] [Related]
10. Cystic fibrosis and bone disease: defective osteoblast maturation with the F508del mutation in cystic fibrosis transmembrane conductance regulator.
Velard F; Delion M; Le Henaff C; Guillaume C; Gangloff S; Jacquot J; Tabary O; Touqui L; Barthes F; Sermet-Gaudelus I
Am J Respir Crit Care Med; 2014 Mar; 189(6):746-8. PubMed ID: 24628315
[No Abstract] [Full Text] [Related]
11. [Question 5. What management for hepatobiliary injury in the course of cystic fibrosis?].
Badet F
Arch Pediatr; 2003 Aug; 10 Suppl 3():495s-504s. PubMed ID: 14671966
[No Abstract] [Full Text] [Related]
12. [Respiratory disease in cystic fibrosis: from physiopathology to therapy. Kinesitherapy and pulmonary transplantation excluded].
Reynaud-Gaubert M
Rev Mal Respir; 1999 Sep; 16(4):495-509. PubMed ID: 10549060
[TBL] [Abstract][Full Text] [Related]
13. Cystic fibrosis-related liver disease: Clinical presentations, diagnostic and monitoring approaches in the era of CFTR modulator therapies.
Dana J; Debray D; Beaufrère A; Hillaire S; Fabre M; Reinhold C; Baumert TF; Berteloot L; Vilgrain V
J Hepatol; 2022 Feb; 76(2):420-434. PubMed ID: 34678405
[TBL] [Abstract][Full Text] [Related]
14. Mild pulmonary, but severe hepatic disease in a cystic fibrosis patient homozygous for a frameshift mutation in the regulatory domain of the CFTR.
Lissens W; Desmyttere S; Bonduelle M; Dab I; Liebaers I; Mercier B; Audrezet MP; Ferec C
J Med Genet; 1993 May; 30(5):446. PubMed ID: 7686577
[No Abstract] [Full Text] [Related]
15. Hepatobiliary disease in patients with cystic fibrosis.
Moyer K; Balistreri W
Curr Opin Gastroenterol; 2009 May; 25(3):272-8. PubMed ID: 19381084
[TBL] [Abstract][Full Text] [Related]
16. Asymptomatic cystic fibrosis diagnosed in an adult evaluated for hematuria.
Reynolds JC; Tiu AB; Berg BW
Am J Kidney Dis; 2002 Jan; 39(1):E3. PubMed ID: 11774129
[TBL] [Abstract][Full Text] [Related]
17. Cystic fibrosis modifier genes.
Davies J; Alton E; Griesenbach U
J R Soc Med; 2005; 98 Suppl 45(Suppl 45):47-54. PubMed ID: 16025767
[TBL] [Abstract][Full Text] [Related]
18. Bilateral spontaneous pneumothorax in a newborn with N1303K mutation of cystic fibrosis (CFTR) gene.
Ataseven F; Ozer S; Yılmaz R; Senaylı A
Tuberk Toraks; 2010; 58(2):181-3. PubMed ID: 20865572
[TBL] [Abstract][Full Text] [Related]
19. Clinical and genetic risk factors for cystic fibrosis-related liver disease.
Wilschanski M; Rivlin J; Cohen S; Augarten A; Blau H; Aviram M; Bentur L; Springer C; Vila Y; Branski D; Kerem B; Kerem E
Pediatrics; 1999 Jan; 103(1):52-7. PubMed ID: 9917439
[TBL] [Abstract][Full Text] [Related]
20. Cystic Fibrosis-related Liver Disease: The Next Challenge.
Baker RD; Baker SS
J Pediatr Gastroenterol Nutr; 2020 Oct; 71(4):421-422. PubMed ID: 32740535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
